Formulation and In-Vitro Evaluation of Taste Masked Fast Disintegrating Tablet Rosuvastatin Calcium

Authors

  • Jadhav Yash Ganesh Department of Pharmaceutics, Mother Teresa College of Pharmacy, NFC Nagar Ghatkesar, Telangana, India-501301. Author
  • T. Ramchander Associate Professor, Mother Teresa College of Pharmacy, NFC Nagar Ghatkesar, Telangana, India-501301. Author
  • P. Aravinda Reddy Principal and Professor, Mother Teresa College of Pharmacy, NFC Nagar Ghatkesar, Telangana, India-501301. Author

DOI:

https://doi.org/10.30904/j.ijctpr.2025.4880

Keywords:

Rosuvastatin, hardness, friability, weight variation, ODTs

Abstract

The present study was aimed at developing oral disintegrating tablets (ODTs) of Rosuvastatin with enhanced solubility and rapid disintegration using a simple and cost-effective method. A suitable UV-Visible spectrophotometric method was established for drug analysis, with λmax identified at 220 nm in phosphate buffer pH 6.8. ODTs were successfully formulated by direct compression technique utilizing pregelatinized starch, banana powder, and corn starch as natural and conventional excipients. All prepared formulations were evaluated for hardness, friability, weight variation, and drug content, and the values were found to be within acceptable limits, confirming good quality and reproducibility. In vitro drug release studies indicated that formulation F3 exhibited the best performance, showing superior release characteristics compared to other batches. Notably, formulations containing banana powder demonstrated enhanced drug release compared to those with other excipients. Overall, the study successfully achieved its objective of formulating Rosuvastatin ODTs using minimal excipients and a simple manufacturing approach, ensuring improved solubility and patient compliance.

Downloads

Published

2025-10-22

Issue

Section

Articles

How to Cite

Yash Ganesh, J., T, R., & P, A. R. (2025). Formulation and In-Vitro Evaluation of Taste Masked Fast Disintegrating Tablet Rosuvastatin Calcium. International Journal of Current Trends in Pharmaceutical Research, 13(02), 111-116. https://doi.org/10.30904/j.ijctpr.2025.4880